IFF to sell pharma solutions business to France's Roquette for $2.85 bln

IFF to sell pharma solutions business to France's Roquette for $2.85 bln
IFF exploring possible sale of pharma solutions business - report
Earnings Results: IFF stock plunges 20% as inventory costs fuel big miss, sales outlook cut
IFF evaluating sale of $1B cosmetics, personal care unit - report
IFF to sell Flavor Specialty Ingredients business for $220M
21.13BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NYSE
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US4595061015
CUSIP
459506101
Sector
Basic Materials
Industry
Specialty Chemicals
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
25.33
PEG Ratio
0.90
Book Value
55.33
Dividend Share
1.6
Dividend Yield
1.93%
Earnings Share
3.23
Wall Street Target Price
91.32
EPS Estimate Current Year
4.50
EPS Estimate Next Year
4.82
EPS Estimate Current Quarter
1.0729
EPS Estimate Next Quarter
1.1541
Most Recent Quarter
-
Revenue TTM
10,787,999,744
Gross Profit TTM
3,920,999,936
EBITDA
1,879,000,064
Profit Margin
7.66%
Return On Assets TTM
2.12%
Return On Equity TTM
6.05%
Revenue Per Share TTM
42.141
Qtly Revenue Growth YOY
-3.60%
Diluted Eps TTM
3.23
Qtly Earnings Growth YOY
-31.00%
Trailing PE
25.33
Forward PE
18
Price Sales TTM
1.9365
Price Book MRQ
1.5157
Enterprise Value Revenue
2
Enterprise Value EBITDA
13
4342.00
2.35%87.11
1.22%203.65
0.00%329.73
-3.65%274.00
-3.34%296.75
-2.85%21.04
-2.00%527.50
-1.98%40.56
-0.42%201.96
-0.35%